Campylobacter jejuni strains from patients with Guillain-Barre syndrome

Emerging Infectious Diseases

Volumn 4, Issue 2, 1998, Pages 263-268

  Allos, Ban Mishu ^a   Lippy, Frank T ^a   Carlsen, Andrea ^a   Washburn, Ronald G ^c   Blaser, Martin J ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3;

BACTERICIDAL ACTIVITY; CAMPYLOBACTER JEJUNI; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESISTANCE; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION SENSITIVITY; PATHOPHYSIOLOGY; REVIEW; SERODIAGNOSIS; STRAIN DIFFERENCE;

EID: 0031834903     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0402.980213     Document Type: Review

References (30)

1. Hughes RAC. Guillain-Barré Syndrome. London: Springer-Verlag; 1990.
2. Asbury AK, Johnson PC. Pathology of peripheral nerves. Philadelphia: WB Saunders; 1978.
3. Winer JB, Hughes RAC, Anderson MJ, Jones DM, Kangro H, Watkins RFP. A prospective study of acute idiopathic neuropathy II. Antecedent events. J Neurol Neurosurg Psychiatry 1988;51:613-8.
4. Mishu B, Ilyas AA, Koski CL, Vriesendorp F, Cook SD, Mithen FA, et al. Serologic evidence of preceding Campylobacter jejuni infection in patients with the Guillain-Barré syndrome. Ann Intern Med 1993;118:947-53.
5. Kuroki S, Saida T, Nukina M, Haruta T, Yoshioka M, Kobayashi Y, et al. Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain B-N-acetylglucosamine residues. Ann Neurol 1993;33:243-7.
6. Rees JH, Soudain SE, Gregson NA, Hughes RAC. Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med 1995;333:1374-9.
7. Allos BM. Campylobacter jejuni infection as a cause of the Guillain-Barré syndrome. Infect Dis Clin North Am 1998;12:173-84.
8. Ho TW, Mishu B, Li CY, Gao CY, Cornblath DR, Griffin JW, et al. Guillain-Barré syndrome in northern China: relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995;118:597-605.
9. Yuki N, Taki T, Takahashi M, Saito K, Yoshino H, Tai T, et al. Molecular mimicry between GQ1b ganglioside and lipopolysaccharide of Campylobacter jejuni isolated from patients with Fisher's syndrome. Ann Neurol 1994;36:791-3.
10. Tauxe RV. Epidemiology of Campylobacter jejuni infections in the United States and other industrialized nations. In: Nachamkin I, Blaser MJ, Tompkins LS, editors. Campylobacter jejuni - current strategy and future trends. Washington: American Society for Microbiology; 1992. p. 9-19.
11. Allos BM, Blaser MJ. Potential role of lipopolysaccharides of Campylobacter jejuni in the development of Guillain-Barré syndrome. Journal of Endotoxin Research 1995;2:237-8.
12. Rees JH, Vaughan RW, Kondeatis E, Hughes RAC. HLA-class II alleles in Guillain-Barré syndrome and Miller Fisher syndrome and their association with preceding Campylobacter jejuni infection. J Neuroimmunol 1995;62:53-7.
13. Fujimoto S, Yuki N, Itoh T, Amako K. Specific serotype of Campylobacter jejuni associated with Guillain-Barré syndrome. J Infect Dis 1992;165:183.
14. Lastovica AJ, Goddard EA, Argent AC. Guillain-Barré syndrome in South Africa associated with Campylobacter jejuni O:41 strains. J Infect Dis 1997;(Suppl 2):S139-S43.
15. Enders U, Karch H, Toyka KV, Heesemann J, Hartung HP. Campylobacter jejuni and Guillain-Barré syndrome. Ann Neurol 1994;35:249.
16. Blaser MJ, Perez-Perez G, Smith PF, Patton CM, Tenover FC, Lastovica AJ, et al. Extraintestinal Campylobacter jejuni and Campylobacter coli infections: host factors and strain characteristics. J Infect Dis 1986;153:552-9.
17. Penner JL, Hennessy JN. Passive hemagglutination technique for serotyping Campylobacter fetus subsp. jejuni on the basis of soluble heat-stable antigens. J Clin Microbiol 1980;2:378-83.
18. Lior H, Woodward DL, Edgar JA, Laroche LJ, Gill P. Serotyping of Campylobacter jejuni by slide agglutination based on heat-labile antigenic factors. J Clin Microbiol 1982;15:761-8.
19. Patton CM, Nicholson, MA, Ostroff SM, Ries AA, Wachsmuth IK, Tauxe RV. Common somatic O and heat-labile serotypes among Campylobacter strains from sporadic infections in the United States. J Clin Microbiol 1993;31:1525-30.
20. Blaser MJ, Smith PF, Hopkins JA, Heinzer I, Bryner JH, Wang WLL. Pathogenesis of Campylobacter fetus infections. Serum resistance associated with high molecular weight surface proteins. J Infect Dis 1987;155:696-709.
21. Gonzales-Valencia G, Perez-Perez GI, Washburn RG, Blaser MJ. Susceptibility of Helicobacter pylori to the bactericidal activity of human serum. Helicobacter 1996;1:28-33.
22. Blaser MJ, Smith PF, Kohler PF. Susceptibility of Campylobacter isolates to the bactericidal activity of human serum. J Infect Dis 1985;151:227-35.
23. Patton CM, Wachsmuth IK. Typing schemes - are current methods useful? In: Nachamkin I, Blaser MJ, Tompkins LS, editor. Campylobacter jejuni - current strategy and future trends. Washington: American Society for Microbiology; 1992. p. 110-28.
24. Fujimoto S, Allos BM, Patton CM, Blaser MJB. Restriction fragment length polymorphism analysis and random amplified polymorphic DNA analysis of Campylobacter jejuni strains isolated from patients with Guillain-Barré syndrome. J Infect Dis 1997;176:1105-8.
25. Blaser MJ, Smith PF, Repine JE, Joiner KA. Pathogenesis of Campylobacter fetus infection. J Clin Invest 1988;81:1434-44.
26. Joiner KA, Hammer CH, Brown EJ, Cole RJ, Frank MM. Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited and released from Salmonella minnesota S218 without causing bacterial death. J Exp Med 1982;155:809-19.
27. Hillert J, Osterman PO, Olerup O. No association with HLA-DR, -DQ, or -DP alleles in Guillain-Barré syndrome. J Neuroimmunol 1991;31:67-72.
28. Winer JB, Briggs D, Welsh K, Hughes RAC. HLA antigens in the Guillain-Barré syndrome. J Neuroimmunol 1988;18:13-6.
29. Yuki N, Fujimoto S, Yamada S, Tsujino Y, Kinoshito A, Itoh T. Serotype of Campylobacter jejuni, HLA, and the Guillain-Barré syndrome. Muscle Nerve 1992;968-9.
30. Allos BM, Blaser MJ. Campylobacter jejuni infection and the Guillain-Barré syndrome: mechanisms and implications. International Journal of Medical Microbiology, Virology, Parasitology, and Infectious Diseases 1994;281:544-8.